Abstract 15039: Oral Carbon Absorbent, AST-120, Protects the Progression of Atherosclerosis in a Chronic Renal Failure Model of Mice via Preserving sFlt-1 Expression Level

Yasuki Nakada,Kenji Onoue,Takuya Kumazawa,Satomi Ishihara,Tomoya Nakano,Hitoshi Nakagawa,Masaru Matsui,Hiroyuki Okura,Yoshihiko Saito

Abstract 15039: Oral Carbon Absorbent, AST-120, Protects the Progression of Atherosclerosis in a Chronic Renal Failure Model of Mice via Preserving sFlt-1 Expression Level

2017

Yasuki Nakada
Kenji Onoue
Takuya Kumazawa
Satomi Ishihara
Tomoya Nakano
Hitoshi Nakagawa
Masaru Matsui
Hiroyuki Okura
Yoshihiko Saito

Background: We reported that expression of soluble Flt-1 (sFlt-1), an endogenous antagonist against the proatherogenic cytokine placental growth factor, is decreased in chronic kidney disease (CKD)...

Keywords:

Antagonist
Cardiology
Endocrinology
Internal medicine
Placental growth factor
Endogeny
Diabetes mellitus
Medicine
Kidney disease
Cytokine
Renal function
chronic renal failure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations